西藏民族大学医学院//西藏民族大学藏药检测技术教育部工程研究中心,陕西 咸阳 712082
ZHANG Xiaoying; E-mail:xyzhang@xzmu.edu.cn
收稿:2026-07-11,
修回:2026-08-03,
录用:2026-08-24,
纸质出版:2026-09-20
移动端阅览
张晓英,谢予荃,张雨婵等.八味沉香丸激活磷脂酰肌醇3-激酶抑制铜死亡改善大鼠急性心肌缺血损伤[J].中山大学学报(医学科学版),2026,47(05):820-832.
ZHANG Xiaoying,XIE yuquan,ZHANG yuchan,et al.Bawei Chenxiang Wan Protects Against Acute Myocardial Ischemia by Activating Phosphatidylinositol 3-Kinase to Inhibit Cuproptosis in Rats[J].Journal of Sun Yat-sen University(Medical Sciences),2026,47(05):820-832.
张晓英,谢予荃,张雨婵等.八味沉香丸激活磷脂酰肌醇3-激酶抑制铜死亡改善大鼠急性心肌缺血损伤[J].中山大学学报(医学科学版),2026,47(05):820-832. DOI: 10.11714/jsysu.med.YX20260105.
ZHANG Xiaoying,XIE yuquan,ZHANG yuchan,et al.Bawei Chenxiang Wan Protects Against Acute Myocardial Ischemia by Activating Phosphatidylinositol 3-Kinase to Inhibit Cuproptosis in Rats[J].Journal of Sun Yat-sen University(Medical Sciences),2026,47(05):820-832. DOI: 10.11714/jsysu.med.YX20260105.
目的
2
研究藏药八味沉香丸(BCW)防治心肌缺血的有效活性部位及机制。
方法
2
建立异丙肾上腺素(ISO)诱导大鼠在体心肌缺血模型、冠脉结扎离体心脏缺血模型,评估BCW全方、醇提物及其不同极性萃取物对心电图ST段、心肌损伤、血流动力学及心肌梗死的影响。检测心肌组织磷脂酰肌醇3-激酶(PI3K)磷酸化水平、铜死亡相关蛋白的表达,以及Cu²⁺含量。利用氧糖剥夺(OGD)心肌细胞损伤模型联合PI3K激动剂和抑制剂验证通路调控关系。
结果
2
BCW全方可改善心肌缺血大鼠心电图ST段抬高(
P
<0.01),降低心肌损伤标志物含量,改善血流动力学,上调PI3K磷酸化水平(
P
<0.01),减少Cu²⁺蓄积(
P
<0.01),缩小心肌梗死范围。BCW醇提物及各萃取物可改善离体大鼠离体心肌缺血,减少Cu²⁺蓄积,其中BCW正丁醇萃取物效果较好(
P
<0.01);其可上调PI3K磷酸化水平(
P
<0.01)、下调铁氧还蛋白还原酶(FDX1)(
P
<0.05)、硫辛酸合酶(LIAS)、二氢硫辛酰胺乙酰转移酶(DLAT)多聚体表达(
P
<0.05)。在OGD诱导心肌细胞模型中,PI3K激动剂可抑制DLAT多聚体表达(
P
<0.05),而PI3K抑制剂可削弱正丁醇萃取物对DLAT多聚体的抑制作用(
P
<0.05)。
结论
2
BCW正丁醇萃取物是改善大鼠心肌缺血的主要有效部位,其机制可能与PI3K激活介导的铜死亡抑制有关。
Objective
2
To investigate the protective effect and underlying mechanisms of the Bawei Chenxiang Wan (BCW) against myocardial ischemic injury.
Methods
2
Myocardial ischemia in vivo was induced in rats by subcutaneous injection of isoproterenol (ISO), and ex vivo ischemia was established by coronary artery ligation in isolated rat hearts. The effects of BCW, alcohol extracts and its polar extracts were evaluated on ST segment on electrocardiogram (ECG), myocardial damage, hemodynamic parameters, and infarct size. The phosphorylation level of phosphatidylinositol 3-kinase (PI3K), the expression of cuproptosis-related proteins, and the content of Cu²⁺ in myocardial tissue were detected. The regulatory relationship of the signaling pathway was verified using an oxygen-glucose deprivation (OGD) myocardial cell injury model, combined with PI3K agonists and inhibitors.
Results
2
BCW ameliorated ST-segment elevation on electrocardiograms(
P
<0.01), reduced serum levels of myocardial injury markers, improved hemodynamic parameters, upregulated PI3K phosphorylation(
P
<0.01), and decre
ased Cu²⁺ accumulation in rats with myocardial ischemia(
P
<0.01). Moreover, BCW reduced the myocardial infarct size. In the isolated rat heart model of ischemia, both the ethanol extract and various solvent fractions of BCW exerted protective effects and reduced Cu²⁺ content, among which the n-butanol fraction exhibited the most potent activity(
P
<0.01). Specifically, the n-butanol fraction upregulated PI3K phosphorylation(
P
<0.01) and downregulated the expression of cuproptosis-related proteins, including ferredoxin reductase 1(FDX1)(
P
<0.05), lipoic acid synthetase(LIAS), and dihydrolipoamide S-acetyltransferase(DLAT) oligomerization(
P
<0.05). In the OGD-induced cardiomyocyte injury model, treatment with a PI3K agonist inhibited DLAT oligomerization(
P
<0.05), whereas co-administration of a PI3K inhibitor attenuated the inhibitory effect of the n-butanol fraction on DLAT oligomer formation(
P
<0.05).
Conclusion
2
The n-butanol fraction of BCW exerts a significant protective effect against myocardial ischemic injury, and its mechanism may involve activation of the PI3K and inhibition of cuproptosis.
Abdelalim PA , Abedi A , Abiodun PO , et al . Global, regional, and national burden of cardiovascular diseases and risk factors in 204 countries and territories, 1990–2023 [J]. J Am Coll Cardiol , 2025 , 86 ( 22 ): 2167 - 2243 .
Liu B , Chang Y , Heng Yang YW , et al . Global, regional, and national burden of ischemic heart disease attributable to metabolic risks: a systematic analysis of global burden of disease [J]. J Geriatr Cardiol , 2025 , 22 ( 3 ): 361 - 368 .
Davidson SM , Adameová A , Barile L , et al . Mitochondrial and mitochondrial-independent pathways of myocardial cell death during ischaemia and reperfusion injury [J]. J Cell Mol Med , 2020 , 24 ( 7 ): 3795 - 3806 .
Du B , Fu Q , Yang Q , et al . Different types of cell death and their interactions in myocardial ischaemia-reperfusion injury [J]. Cell Death Discov , 2025 , 11 ( 1 ): 19 - 87 .
Tsvetkov P , Coy S , Petrova B , et al . Copper induces cell death by targeting lipoylated TCA cycle proteins [J]. Science , 2022 , 375 ( 6586 ): 1254 - 1261 .
Hu J , Bao X , Ting M , et al . Precision targeting of FDX1-mediated cuproptosis by a ROS-responsive hydrogel for myocardial ischaemia-reperfusion injury treatment [J]. Theranostics , 2026 , 16 ( 3 ): 1281 - 1294 .
Zhang Y , Gui Y , Belke D , et al . Monomethyl fumarate confers cardioprotection after myocardial infarction via HCAR2-dependent activation of PI3K/Akt signalling [J]. Cell Death Discov , 2025 , 12 ( 1 ): 18 - 63 .
Zhang H , Wang H , Kang K , et al . 1,3-butanediol enhances autophagy via PI3K/Akt/FOXO3 pathway to ameliorate cardiac remodelling post-myocardial infarction [J]. Eur J Pharmacol , 2026 , 1015 : 178539 .
官敏 , 岳栋芳 , 李彩霞 , 等 . 基于网络药理学与动物实验探究八味沉香散对阿霉素心脏损伤的保护作用及机制 [J]. 中国高原医学与生物学杂志 , 2024 , 45 ( 3 ): 179 - 189 .
Guan M , Yue DF , Li CX , et al . Research on the protective effects and mechanism of Bawei Chenxiang Powder on the cardiac injury induced by adriamycin based on network pharmacology and animal experiments [J]. Chin High Alt Med Biol , 2024 , 45 ( 3 ): 179 - 189 .
岳栋芳 , 李彩霞 , 官敏 , 等 . 基于网络药理学从线粒体自噬途径探讨八味沉香散抗缺血性心脏病的作用机制 [J]. 中国药理学通报 , 2023 , 39 ( 10 ): 1957 - 1965 .
Yue DF , Li CX , Guan M , et al . Mechanism of Bawei Chenxiang powder in treatment of ischemic heart disease through mitophagy based on network pharmacology [J]. Chin Pharmacol Bull , 2023 , 39 ( 10 ): 1957 - 1965 .
李永芳 , 杨梅 , 寇毅英 , 等 . 八味沉香散对异丙肾上腺素诱导大鼠心肌缺血损伤的保护作用 [J]. 中药药理与临床 , 2008 , 24 ( 2 ): 63 - 65 .
Li YF , Yang M , Kou YY , et al . Cardioprotective effects of Baweichenxiang Powder on myocardial injury induced by isoproterenol in rats [J]. Pharmacol Clin Chin Mater Med , 2008 , 24 ( 2 ): 63 - 65 .
李莹环 , 祁雅琼 , 李永芳 . 基于网络药理学及实验验证探究八味沉香散治疗冠心病的药效物质基础 [J]. 中国中医药信息杂志 , 2025 , 32 ( 1 ): 69 - 77 .
Li YH , Qi YQ , Li YF . Exploration on the pharmacodynamic material basis of Bawei Chenxiang Powder in treating coronary heart disease based on network pharmacology and experimental verification [J]. Chin J Inf Tradit Chin Med , 2025 , 32 ( 1 ): 69 - 77 .
Zhang XY , Zhang ZY , Wang PX , et al . Bawei chenxiang wan ameliorates cardiac hypertrophy by activating AMPK/PPAR-α signalling pathway improving energy metabolism [J]. Front Pharmacol , 2021 , 12 : 653901 .
Han YW , Li SD , Zhang ZY , et al . Bawei chenxiang wan ameliorates right ventricular hypertrophy in rats with high altitude heart disease by SIRT3-HIF1α-PDK/PDH signalling pathway improving fatty acid and glucose metabolism [J]. BMC Complement Med Ther , 2024 , 24 ( 1 ): 190 .
多布杰 . 藏医内科学 [M]. 北京 : 民族出版社 , 2004 : 111 .
Du BJ . Internal medicine of Tibetan medicine [M]. Beijing : The Ethnic Publishing House , 2004 : 111 .
才让南加 , 周则 , 仁增多杰 , 等 . 《四部医典》治疗心脏疾病方剂内在配伍规律研究 [J]. 时珍国医国药 , 2015 , 26 ( 12 ): 2982 - 2983 .
Cai RNJ , Zhou Z , Ren ZDJ , et al . Study on the inherent compatibility rules of prescriptions for heart diseases in Four Medical Classics [J]. Lishizhen Med Mater Med Res , 2015 , 26 ( 12 ): 2982 - 2983 .
徐季轩 , 马晓静 , 陈泓颖 , 等 . 我国主要少数民族医药防治缺血性心脏病研究概述 [J]. 中国实验方剂学杂志 , 2022 , 28 ( 17 ): 235 - 247 .
Xu JX , Ma XJ , Chen HY , et al . Overview of research on prevention and treatment of ischemic heart disease by major ethnic minority medicines in China [J]. Chin J Exp Tradit Med Formulae , 2022 , 28 ( 17 ): 235 - 247 .
尕藏扎西 , 才让措 , 贡却坚赞 , 等 . 藏药安神丸治疗心隆病的机理初探 [J]. 时珍国医国药 , 2017 , 28 ( 8 ): 1961 - 1962 .
Ga ZZX , Cai RC , Gong QJZ , et al . Preliminary study on the mechanism of Tibetan medicine Anshen Pill in the treatment of heart lung disease [J]. Lishizhen Med Mater Med Res , 2017 , 28 ( 8 ): 1961 - 1962 .
Yue Z , Zhang Y , Zhang W , et al . Kaempferol alleviates myocardial ischaemia injury by reducing oxidative stress via the HDAC3-mediated Nrf2 signalling pathway [J]. J Adv Res , 2025 , 75 : 755 - 764 .
Chen X , Yu X , Zhong S , et al . ALDH2/eIF3E interaction modulates protein translation critical for cardiomyocyte ferroptosis in acute myocardial ischaemia injury [J]. Circulation , 2026 , 153 ( 3 ): 164 - 184 .
Bell RM , Mocanu MM , Yellon DM . Retrograde heart perfusion: the Langendorff technique of isolated heart perfusion [J]. J Mol Cell Cardiol , 2011 , 50 ( 6 ): 940 - 950 .
王嘉童 , 康露璐 , 周凤 , 等 . 八味沉香丸不同提取物的药效比较与成分研究 [J]. 中国中药杂志 , 2025 , 50 ( 11 ): 3035 - 3042 .
Wang JT , Kang LL , Zhou F , et al . Studies on pharmacological effects and chemical components of different extracts from Bawei Chenxiang Pills [J]. China J Chin Mater Med , 2025 , 50 ( 11 ): 3035 - 3042 .
苏玫匀 , 王佩 , 刘艳萍 . GC法同时测定藏药八味沉香散中挥发性指标成分含量 [J]. 药物流行病学杂志 , 2024 , 33 ( 11 ): 1247 - 1253 .
Su MY , Wang P , Liu YP . Simultaneous determination of volatile index components in Tibetan medicine Bawei Chenxiang Powder by GC [J]. Chin J Pharmacoepidemiol , 2024 , 33 ( 11 ): 1247 - 1253 .
黄艳菲 , 叶琪 , 田一凡 , 等 . 南酸枣的化学成分研究及其心血管治疗潜力分析(英文) [J]. Acupuncture and Herbal Medicine , 2025 , 5 ( 2 ): 246 - 269 .
Huang YF , Ye Q , Tian YF , et al . Study on chemical constituents of Choerospondias axillaris and its therapeutic potential for cardiovascular diseases [J]. Acupunct Herb Med , 2025 , 5 ( 2 ): 246 - 269 .
李晓雅 , 次旺仁增 , 罗亚敏 . 藏药八味沉香丸化学成分的超高效液相色谱-线性离子阱/静电场轨道阱组合式高分辨质谱分析及不同厂家成分差异的研究 [J]. 西北药学杂志 , 2026 , 41 ( 3 ): 49 - 70 .
Li XY , Ciwang RZ , Luo YM . UHPLC-LTQ/Orbitrap MS analysis of chemical constituents of Tibetan medicine Bawei Chenxiang Pills and component differences among different manufacturers [J]. Northwest Pharm J , 2026 , 41 ( 3 ): 49 - 70 .
Hu S , Lv L , Hu W , et al . Quercetin improves myocardial ischaemia-reperfusion injury by regulating macrophage M2 polarization through Bcl-2/Beclin-1 complex [J]. Eur J Med Res , 2025 , 30 ( 1 ): 780 .
李华爽 , 刘永建 , 杨洪柳 , 等 . 诃子化学成分、药理作用机制、质量控制及炮制研究进展 [J]. 天然产物研究与开发 , 2022 , 34 ( 12 ): 2130 - 2141 .
Li HS , Liu YJ , Yang HL , et al . Research progress on chemical constituents, pharmacological mechanism, quality control and processing of Terminalia chebula Retz .[J]. Nat Prod Res Dev , 2022 , 34 ( 12 ): 2130 - 2141 .
Liu P , Chen J , Qi J , et al . Hesperetin ameliorates ischemia/hypoxia-induced myocardium injury via inhibition of oxidative stress, apoptosis, and regulation of Ca²⁺ homeostasis [J]. Phytother Res , 2023 , 37 ( 5 ): 1787 - 1805 .
Yue Z , Zhang Y , Zhang W , et al . Kaempferol alleviates myocardial ischemia injury by reducing oxidative stress via the HDAC3-mediated Nrf2 signaling pathway [J]. J Adv Res , 2010 , 75 ( 10 ): 10 .
Yu QT , Zhang N , Gan XW , et al . EGCG attenuated acute myocardial infarction by inhibiting ferroptosis via miR-450b-5p/ACSL4 axis [J]. Phytomedicine , 2023 , 119 : 154999 .
张子路 , 秦合伟 . 铜死亡与动脉粥样硬化的关系及其靶向治疗的研究进展 [J]. 中山大学学报(医学科学版) , 2025 , 46 ( 4 ): 558 - 567 .
Zhang ZL , Qin HW . Research progress on relationship between cuproptosis and atherosclerosis and its targeted therapy [J]. J Sun Yat-Sen Univ(Med Sci) , 2025 , 46 ( 4 ): 558 - 567 .
Nebojša MT , Tasic D , Petar O , et al . Copper and zinc concentrations in atherosclerotic plaque and serum in relation to lipid metabolism in patients with carotid atherosclerosis [J]. Vojnosanit Pregl , 2015 , 72 ( 9 ): 801 - 806 .
Liu RX , Yao JL , Chen KX , et al . Association between biomarkers of zinc and copper status and heart failure: a meta-analysis [J]. ESC Heart Fail , 2024 , 11 ( 5 ): 2546 - 2556
Liu S , Xie K , Tong R , et al . Integrated multi-omics and experimental validation reveal FDX1/LIAS-mediated cuproptosis as a potential driver of diabetic disease [J]. Biol Trace Elem Res , 2026 , 204 ( 3 ): 1969 - 1982 .
Liu XM , Liu HP , Wang N , et al . The interactive toxic effect of homocysteine and copper on cardiac microvascular endothelial cells during ischemia-reperfusion injury [J]. Chem Biol Interact , 2025 , 408 : 111387 .
Deng R , Zhou J . The role of PI3K/AKT signalling pathway in myocardial ischaemia-reperfusion injury [J]. Int Immunopharmacol , 2023 , 123 : 110714 .
Liu S , He Y , Shi J , et al . STAT1-activated LINC00961 regulates myocardial infarction by the PI3K/AKT/GSK3β signalling pathway [J]. J Cell Biochem , 2019 , 120 ( 8 ): 13226 - 13236 .
Wang W , Zhang Z , Liu R , et al . Exploration of the potential bioactive compounds and functional mechanism of Chaihu Sanshen capsule in ameliorating myocardial ischaemia-reperfusion injury: a serum pharmaco-chemistry with network pharmacology analysis [J]. J Cell Mol Med , 2025 , 29 ( 14 ): e70666 .
陈宏 , 杨梅 , 李永芳 , 等 . 八味沉香散50%醇提液对急性心肌缺血大鼠心电图及形态学的影响 [J]. 陕西中医 , 2010 , 31 ( 3 ): 365 - 367 .
Chen H , Yang M , Li YF , et al . Effects of 50% alcohol extract of Bawei Chenxiang Powder on ECG and morphology in rats with acute myocardial ischemia [J]. Shaanxi J Tradit Chin Med , 2010 , 31 ( 3 ): 365 - 367 .
宫佰会 , 岳栋芳 , 李彩霞 , 等 . 八味沉香散含药血清对H9c2细胞氧糖剥夺损伤的保护机制研究 [J]. 中国药房 , 2023 , 34 ( 1 ): 40 - 46 .
Gong BH , Yue DF , Li CX , et al . Study on the protective mechanism of Bawei chenxiang powder containing serum on H9c2 cells injured byoxygen-glucose deprivation [J]. China Pharm (Chongqing, China) , 2023 , 34 ( 1 ): 40 - 46 .
杨梅 , 李永芳 , 寇毅英 , 等 . 藏药八味沉香散50%醇提部位对急性心肌缺血大鼠作用的研究 [J]. 新中医 , 2011 , 43 ( 9 ): 97 - 99 .
Yang M , Li YF , Kou YY , et al . Effects of 50% Ethanol-extract from Bawei Chenxiang Powder on Acute Myocardium Ischemia Rats [J]. New J Tradit Chin Med , 2011 , 43 ( 9 ): 97 - 99 .
0
浏览量
57
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621
